Max Jan is an Assistant Professor of Pathology at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS). He is a Molecular Pathologist at the Broad Institute of MIT and Harvard.  Following undergraduate studies at Princeton University, he completed his PhD at Stanford University in the labs of Drs. Irv Weissman and Ravi Majeti, studying the clonal evolution of pre-leukemic hematopoietic stem cells antecedent to leukemia. After medical school at UCSF, Clinical Pathology residency at MGH, and Molecular Pathology fellowship at HMS, he completed postdoctoral studies in the labs of Drs. Marcela Maus and Ben Ebert, where he developed molecular switches regulated by lenalidomide and with them ON- and OFF-switch CAR T cells. The Jan lab’s core interests are synthetic biology, targeted protein degradation, and cellular immunotherapy.